cancertechinsights.blogspot.com cancertechinsights.blogspot.com

cancertechinsights.blogspot.com

Cancer Technology and Insights

Latest developments in Oncology market trends and intelligence

http://cancertechinsights.blogspot.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR CANCERTECHINSIGHTS.BLOGSPOT.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

July

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.8 out of 5 with 5 reviews
5 star
4
4 star
1
3 star
0
2 star
0
1 star
0

Hey there! Start your review of cancertechinsights.blogspot.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

10.1 seconds

FAVICON PREVIEW

  • cancertechinsights.blogspot.com

    16x16

  • cancertechinsights.blogspot.com

    32x32

CONTACTS AT CANCERTECHINSIGHTS.BLOGSPOT.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Cancer Technology and Insights | cancertechinsights.blogspot.com Reviews
<META>
DESCRIPTION
Latest developments in Oncology market trends and intelligence
<META>
KEYWORDS
1 posted by
2 sally church
3 2 comments
4 labels business
5 image via wikipedia
6 no comments
7 labels aids
8 cancer
9 harald zur hausen
10 human papillomavirus
CONTENT
Page content here
KEYWORDS ON
PAGE
posted by,sally church,2 comments,labels business,image via wikipedia,no comments,labels aids,cancer,harald zur hausen,human papillomavirus,luc montagnier,meeting in boston,labels arimidex,breast cancer,health,pharma,strategy,treatment,herceptin,vaccines
SERVER
GSE
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Cancer Technology and Insights | cancertechinsights.blogspot.com Reviews

https://cancertechinsights.blogspot.com

Latest developments in Oncology market trends and intelligence

INTERNAL PAGES

cancertechinsights.blogspot.com cancertechinsights.blogspot.com
1

Cancer Technology and Insights: 2008 Nobel Prize for medicine honours 3 vaccine researchers

http://cancertechinsights.blogspot.com/2008/10/2008-nobel-prize-for-medicine-honours-3.html

Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Monday, October 6, 2008. 2008 Nobel Prize for medicine honours 3 vaccine researchers. Somewhat controversially, the Nobel committee has awarded the Prize for Physiology and Medicine to three Europeans. Harald zur Hausen. Discovered human papilloma viruses (HPV), which causes cervical cancer and two Frenchmen, Françoise Barré-Sinoussi and Luc Montagnier. In the 1990s, however, the U.S. government acknow...Nobel...

2

Cancer Technology and Insights: BRCA mutations in breast cancer

http://cancertechinsights.blogspot.com/2008/07/brca-mutations-in-breast-cancer.html

Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Saturday, July 26, 2008. BRCA mutations in breast cancer. Genetic testing for BRCA1. Mutations can provide important information for women who are concerned about their breast and ovarian cancer risks and need to make relevant prevention and medical management decisions. Cancer risks in a population-based study. Of BRCA1/2 mutation carriers have been recently estimated, but the numbers are still in their infan...

3

Cancer Technology and Insights: Can a vaccine help fight breast cancer?

http://cancertechinsights.blogspot.com/2008/09/can-vaccine-help-fight-breast-cancer.html

Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Sunday, September 21, 2008. Can a vaccine help fight breast cancer? A new vaccine in development targets breast cancers that proliferate aggressively in response to the growth factor HER-2. About 25-30% of women with breast cancer have HER-2 positive tumours. Herceptin (trastuzumab). The researchers published in the findings in Cancer Research. The vaccine, developed at the Karmanos Cancer Center in Detroit, u...

4

Cancer Technology and Insights: October 2008

http://cancertechinsights.blogspot.com/2008_10_01_archive.html

Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Monday, October 6, 2008. 2008 Nobel Prize for medicine honours 3 vaccine researchers. Somewhat controversially, the Nobel committee has awarded the Prize for Physiology and Medicine to three Europeans. Harald zur Hausen. Discovered human papilloma viruses (HPV), which causes cervical cancer and two Frenchmen, Françoise Barré-Sinoussi and Luc Montagnier. In the 1990s, however, the U.S. government acknow...Nobel...

5

Cancer Technology and Insights: How is cancer formed?

http://cancertechinsights.blogspot.com/2008/07/how-is-cancer-formed.html

Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Sunday, July 20, 2008. How is cancer formed? All cancers start with mutations in one single cell. The mutations are located in the cell's DNA. And may be inherited, although less than 10% of all cancer mutations are inherited. Usually, the mutation arises as a result of environmental factors. The DNA mutation may be a single nucleotide change, or a deletion or duplication of the DNA sequence. They are replaced...

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

hematologymarketinsights.blogspot.com hematologymarketinsights.blogspot.com

Hematology Competitive Insights: Second-line treatment in CML

http://hematologymarketinsights.blogspot.com/2008/07/second-line-treatment-in-cml.html

Tuesday, July 29, 2008. Second-line treatment in CML. MD Anderson Cancer Center recently published a new article in Blood. Looking at second-line treatment with tyrosine kinase therapies with nilotinib. Failure. This is a crucial question - how long should patients receive their new therapy before considering alternative treatments? Thanks for this useful post. Here is some additional information about the genetics of this condition that was written by our Genetic Counselor and other genetic professi...

hematologymarketinsights.blogspot.com hematologymarketinsights.blogspot.com

Hematology Competitive Insights: May 2008

http://hematologymarketinsights.blogspot.com/2008_05_01_archive.html

Monday, May 12, 2008. Knocking out cancer cells in Leukemia. Cancer initiating cells (CICs) or leukemia initiating cells (LICs) are stealth populations impervious to conventional chemotherapy and resistant to targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that are the cause of the disease’s re-emergence. Researchers at the Beth Israel Deaconess Medical Center. Their findings, which appear in Nature. The concept is a very simple one; 90% of exis...

oncologymarkettrends.blogspot.com oncologymarkettrends.blogspot.com

Oncology Market Trends: Cancer Research Blog Carnival #14 — Sciencebase Science Blog

http://oncologymarkettrends.blogspot.com/2008/10/cancer-research-blog-carnival-14.html

What's new in the world of cancer. Monday, October 6, 2008. Cancer Research Blog Carnival #14 — Sciencebase Science Blog. Well, this morning I had a nice surprise after finding that some posts in my science and cancer blog made the Cancer Research Blog Carnival. This weekend, thanks to the host David Bradley and ScienceBase. You can read more about this great Carnival concept on his blog. About the online event. Related articles by Zemanta. Cancer Research Blog Carnival. Cancer Research Blog Carnival.

hematologymarketinsights.blogspot.com hematologymarketinsights.blogspot.com

Hematology Competitive Insights: September 2008

http://hematologymarketinsights.blogspot.com/2008_09_01_archive.html

Thursday, September 11, 2008. To all those who lost their lives on 9/11, there will be no blog posts today. We will remember them. Subscribe to: Posts (Atom). Pharmaceuticals, biotechnology, marketing strategy, cancer, oncology, competitive intelligence, landscape opportunity assessments, portfolio analysis. View my complete profile. Icarus Consultants, Inc. Follow Me on Twitter! Subscribe Now: Feed Icon. Subscribe in a reader. Enter your email address:. Ban academics from talking to ministers?

hematologymarketinsights.blogspot.com hematologymarketinsights.blogspot.com

Hematology Competitive Insights: Forgotten side of the Iraq war: shortage of meds for cancer patients

http://hematologymarketinsights.blogspot.com/2008/07/forgotten-side-of-iraq-war-shortage-of.html

Friday, July 25, 2008. Forgotten side of the Iraq war: shortage of meds for cancer patients. This interesting (and sad) letter in the New England Journal of Medicine. Highlights the shortage of chemotherapy treatments for children suffering from leukemia:. There was a significant inverse relationship between the amount of prescribed chemotherapy that was administered and the risk of relapse.". Subscribe to: Post Comments (Atom). View my complete profile. Icarus Consultants, Inc. Follow Me on Twitter!

hematologymarketinsights.blogspot.com hematologymarketinsights.blogspot.com

Hematology Competitive Insights: Precise location of an oncogene may determine the onset of childhood leukemia

http://hematologymarketinsights.blogspot.com/2008/07/precise-location-of-oncogene-may.html

Monday, July 14, 2008. Precise location of an oncogene may determine the onset of childhood leukemia. With intensive treatment involving chemotherapy, over half of children are cured. But scientists hope to be able to develop targeted therapies that are less toxic than chemotherapy, based on knowledge of the biological processes behind T-ALL. VIB-KU.Leuven) indicates that the location in the cell where these proteins are found plays an important role in the entire carcinogenic mechanism. Many forms of ca...

hematologymarketinsights.blogspot.com hematologymarketinsights.blogspot.com

Hematology Competitive Insights: Stand Up to Cancer!

http://hematologymarketinsights.blogspot.com/2008/07/stand-up-to-cancer.html

Wednesday, July 2, 2008. Stand Up to Cancer! Stand Up To Cancer, a new initiative to raise philanthropic dollars for accelerating ground-breaking research, launched recently through a large collaboration uniting the major television networks, entertainment industry executives, celebrities and prominent leaders in cancer research and patient advocacy. In addition to the nationally televised network fundraising event, other key elements of the initiative include:. The Stand: An interactive Facebook applica...

hematologymarketinsights.blogspot.com hematologymarketinsights.blogspot.com

Hematology Competitive Insights: Cancer: tracking progress for the treatment of CML

http://hematologymarketinsights.blogspot.com/2008/07/cancer-tracking-progress-for-treatment.html

Sunday, July 20, 2008. Cancer: tracking progress for the treatment of CML. This fascinating short video interviews some of the top leukemia doctors around the world and looks at how tracking faulty chromosomes is now routine for people with chronic myeloid leukemia. Experts such as Dr Brian Druker and Prof. John Goldman explain what sophisticated laboratory tests can tell about treatment success:. Haematology Lectures and Ebooks. Good blog.valuable,precious information.keep updating. Follow Me on Twitter!

oncologymarkettrends.blogspot.com oncologymarkettrends.blogspot.com

Oncology Market Trends: Eeek, I've been tagged! Now what?

http://oncologymarkettrends.blogspot.com/2008/09/eeek-ive-been-tagged-now-what.html

What's new in the world of cancer. Tuesday, September 2, 2008. Eeek, I've been tagged! I got tagged by my friend Sarah Arrow this morning. She's a lovely Essex lass who is the salt of the earth and would do anything for her friends. You can find her on Twitter. Or her excellent courier blog. Being tagged is a game bloggers play where they have to write six random things about their self, and tag six other people. It's a great way to spread the word about other people's blogs. 3 Curry is my favourite food.

UPGRADE TO PREMIUM TO VIEW 39 MORE

TOTAL LINKS TO THIS WEBSITE

48

OTHER SITES

cancerteamofamerica.com cancerteamofamerica.com

cancerteamofamerica.com at Directnic

cancerteamusa.com cancerteamusa.com

cancerteamusa.com at Directnic

cancerteamusa.net cancerteamusa.net

Cancer Team USA :: Home

This PDF is the result of many questions and concerns expressed over the past few years regarding the techniques and methods available, to date, for the isolation of CTC’s (circulating tumor cells) and to explore their potentials and weaknesses. A collection of RGCC International newsletters. Presenting your Business has never been so easy. Pellentesque ultricies ligula vel neque dictum, eu mollis tortor adipiscing. 2015 Cancer Team USA.

cancerteatmentcenterofhazelton.com cancerteatmentcenterofhazelton.com

Cancer Treatment & Care | Advanced Radiation Therapy | Hazleton Pennsylvania

Hazleton Cancer Treatment Center Advanced Radiation Therapy. American Cancer Society Resource Center now located at Hazleton. Learn more about ACS Resource Center. Welcome to the Cancer Treatment Center at Hazleton – offering patients in Greater Hazleton and communities throughout Luzerne County the most technologically advanced radiation therapies from our new location at 1701 E. Broad St. in Hazleton. The Cancer Treatment Center at Hazleton offers several other advanced treatment options, including ext...

cancerteatmentcenterofhazleton.com cancerteatmentcenterofhazleton.com

Cancer Treatment & Care | Advanced Radiation Therapy | Hazleton Pennsylvania

Hazleton Cancer Treatment Center Advanced Radiation Therapy. American Cancer Society Resource Center now located at Hazleton. Learn more about ACS Resource Center. Welcome to the Cancer Treatment Center at Hazleton – offering patients in Greater Hazleton and communities throughout Luzerne County the most technologically advanced radiation therapies from our new location at 1701 E. Broad St. in Hazleton. The Cancer Treatment Center at Hazleton offers several other advanced treatment options, including ext...

cancertechinsights.blogspot.com cancertechinsights.blogspot.com

Cancer Technology and Insights

Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Monday, August 24, 2009. Resumption after an extended hiatus. Things have been really insanely busy on the work front over the last year, necessitating some radical prioritisation and thus I have only posted on Pharma Strategy Blog. Instead of here and Oncology Market Trends. Normal service will resume shortly. Links to this post. Monday, October 6, 2008. Zur Hausen discovered two high-risk types of the HPV vi...

cancertechnologies.com cancertechnologies.com

Cancer Technologies - Tucson Arizona - Welcome!

Welcome to Cancer Technologies! We are a Tucson based company specializing in functional and promotional devices for oncology physicians and nurses. With over 30 years of experience in drug development and pharmacology/toxicology, Cancer Technologies is proud to present our company and work to you. Please look around our website, and Contact Us. If you have any questions or needs! Below, you can contact us via telephone or mail, or you can click here. To contact us directly by email.

cancertechnology.co.uk cancertechnology.co.uk

Cancer Research Technology

Advancing discoveries to beat cancer. Alliance of translational research centres established to accelerate global drug development. Astex Pharmaceuticals Earns $5.4 M Milestone on PhI Trial Initiation of a FGFR Kinase Inhibitor. CRT and ADC Therapeutics join forces on Antibody Drug Conjugates. CRT and Teva Pharmaceuticals Form R&D Alliance for Cancer DNA Damage Response Drugs. CRT, The Institute of Cancer Research and Merck Serono sign WNT licensing deal. CRUK Cambridge Institute Symposium. CRT and Astra...

cancertechnology.com cancertechnology.com

Cancer Research Technology

Advancing discoveries to beat cancer. Alliance of translational research centres established to accelerate global drug development. Astex Pharmaceuticals Earns $5.4 M Milestone on PhI Trial Initiation of a FGFR Kinase Inhibitor. CRT and ADC Therapeutics join forces on Antibody Drug Conjugates. CRT and Teva Pharmaceuticals Form R&D Alliance for Cancer DNA Damage Response Drugs. CRT, The Institute of Cancer Research and Merck Serono sign WNT licensing deal. CRUK Cambridge Institute Symposium. CRT and Astra...

cancertechnology.umd.edu cancertechnology.umd.edu

NCI-UMD Partnership for Integrative Cancer Research

NCI-UMD Partnership for Integrative Cancer Research. The University of Maryland and the National Cancer Institute officially created the Partnership for Integrative Cancer Research in May 2010. Through this Partnership, students, professors, and investigators aim to solve the most pressing problems in cancer research by bringing together the expertise and resources in the mathematical sciences. Center for Cancer Research.

cancertecomense.org cancertecomense.org

Asociación Contra el Cáncer Tecomense I.A.P.

Asociación Contra el Cáncer Tecomense. Bienvenido(a) gracias por visitar nuestra página, la Ascociación le brinda acceso a información valiosa sobre el cáncer. Desde esta página usted podrá acceder a información oportuna, así como a diversos recursos disponibles que podrían ser de mucha utilidad en su lucha contra el cáncer. Recuerda. Prevenir puede salvar tu vida. Gracias por apoyarnos día con día. Usted puede apoyar la labor que realizamos en la ASOCIACION CONTRA EL CANCER TECOMENSE IAP.